OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, RESPONSE Spine systems, Bandloc, and Pediguard.
Read More…
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Phone574-268-6379
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$57.56 million
Profitability
Miscellaneous
Employees80
Next Earnings Date3/4/2020 (Confirmed)
OptionableNot Optionable
Orthopediatrics (NASDAQ:KIDS) Frequently Asked Questions
What is Orthopediatrics' stock symbol?
Orthopediatrics trades on the NASDAQ under the ticker symbol "KIDS."
How were Orthopediatrics' earnings last quarter?
Orthopediatrics Corp (NASDAQ:KIDS) issued its quarterly earnings results on Thursday, November, 7th. The company reported ($0.18) earnings per share for the quarter, missing the consensus estimate of ($0.17) by $0.01. The company had revenue of $20.74 million for the quarter, compared to the consensus estimate of $19.87 million. Orthopediatrics had a negative net margin of 15.80% and a negative return on equity of 12.12%. Orthopediatrics's revenue was up 31.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.15) earnings per share. View Orthopediatrics' Earnings History.
When is Orthopediatrics' next earnings date?
How can I listen to Orthopediatrics' earnings call?
Orthopediatrics will be holding an earnings conference call on Wednesday, March 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.
What guidance has Orthopediatrics issued on next quarter's earnings?
Orthopediatrics issued an update on its fourth quarter 2019
Pre-Market earnings guidance on Monday, January, 13th. The company provided EPS guidance of for the period. The company issued revenue guidance of $19-19 million, compared to the consensus revenue estimate of $18.24 million.
What price target have analysts set for KIDS?
5 equities research analysts have issued 12 month target prices for Orthopediatrics' stock. Their forecasts range from $44.00 to $54.00. On average, they anticipate Orthopediatrics' stock price to reach $49.00 in the next year. View Analyst Price Targets for Orthopediatrics.
What is the consensus analysts' recommendation for Orthopediatrics?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Orthopediatrics in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Orthopediatrics.
Has Orthopediatrics been receiving favorable news coverage?
News articles about KIDS stock have been trending extremely negative on Thursday, according to InfoTrie Sentiment. InfoTrie ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Orthopediatrics earned a news sentiment score of -4.3 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Orthopediatrics.
Who are some of Orthopediatrics' key competitors?
Some companies that are related to Orthopediatrics include Cantel Medical (CMD), Glaukos (GKOS), Irhythm Technologies (IRTC), Merit Medical Systems (MMSI), Inspire Medical Systems (INSP), AtriCure (ATRC), Cardiovascular Systems (CSII), Silk Road Medical (SILK), Atrion (ATRI), Tactile Systems Technology (TCMD), Shockwave Medical (SWAV), Luminex (LMNX), Axonics Modulation Technologies (AXNX), Cryolife (CRY) and Intersect ENT (XENT).
What other stocks do shareholders of Orthopediatrics own?
Who are Orthopediatrics' key executives?
Orthopediatrics' management team includes the folowing people:
- Mr. Mark C. Throdahl, Pres, CEO & Director (Age 68)
- Mr. Fred L. Hite, CFO & Director (Age 51)
- Mr. Daniel J. Gerritzen, VP of Legal & HR, Gen. Counsel and Sec. (Age 49)
- Mr. David R. Bailey, Exec. VP (Age 40)
- Mr. Gregory A. Odle, Exec. VP of Commercialization (Age 49)
When did Orthopediatrics IPO?
(KIDS) raised $52 million in an initial public offering (IPO) on Thursday, October 12th 2017. The company issued 4,000,000 shares at $12.00-$14.00 per share. Piper and Jaffray Stifel acted as the underwriters for the IPO and William Blair and BTIG were co-managers.
Who are Orthopediatrics' major shareholders?
Orthopediatrics' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Riverbridge Partners LLC (4.48%), Massachusetts Financial Services Co. MA (4.21%), Driehaus Capital Management LLC (2.93%), FMR LLC (2.52%), Lord Abbett & CO. LLC (1.61%) and State Street Corp (1.01%). Company insiders that own Orthopediatrics stock include Daniel J Gerritzen, David R Bailey, David R Pelizzon, Fred Hite, Kevin Unger and Mark C Throdahl. View Institutional Ownership Trends for Orthopediatrics.
Which institutional investors are selling Orthopediatrics stock?
KIDS stock was sold by a variety of institutional investors in the last quarter, including Prospect Capital Advisors LLC, Schonfeld Strategic Advisors LLC, New York State Common Retirement Fund, Blair William & Co. IL, Victory Capital Management Inc., Stifel Financial Corp, Brasada Capital Management LP and Victory Capital Management Inc.. Company insiders that have sold Orthopediatrics company stock in the last year include David R Bailey and Mark C Throdahl. View Insider Buying and Selling for Orthopediatrics.
Which institutional investors are buying Orthopediatrics stock?
KIDS stock was purchased by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, CWM LLC, FMR LLC, Parkman Healthcare Partners LLC, Bank of America Corp DE, Massachusetts Financial Services Co. MA, Monashee Investment Management LLC and Royce & Associates LP. View Insider Buying and Selling for Orthopediatrics.
How do I buy shares of Orthopediatrics?
Shares of KIDS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Orthopediatrics' stock price today?
One share of KIDS stock can currently be purchased for approximately $49.00.
How big of a company is Orthopediatrics?
Orthopediatrics has a market capitalization of $819.43 million and generates $57.56 million in revenue each year. The company earns $-12,020,000.00 in net income (profit) each year or ($0.96) on an earnings per share basis. Orthopediatrics employs 80 workers across the globe.View Additional Information About Orthopediatrics.
What is Orthopediatrics' official website?
How can I contact Orthopediatrics?
Orthopediatrics' mailing address is 2850 Frontier Drive, Warsaw IN, 46582. The company can be reached via phone at 574-268-6379 or via email at [email protected]
MarketBeat Community Rating for Orthopediatrics (NASDAQ KIDS)
MarketBeat's community ratings are surveys of what our community members think about Orthopediatrics and other stocks. Vote "Outperform" if you believe KIDS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe KIDS will underperform the S&P 500 over the long term. You may vote once every thirty days.
